| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2024 | A Agilent Technologies, Inc. | McDonnell Padraig71 | President And CEO | Sell | 1,958 | $145.00 | $283,910.00 | -7.5% | -8.3% | -13.3% | |
| Aug 21, 2024 | GRAL Grail, Inc. | Freidin Aaron | Chief Financial Officer | Sell | 15,641 | $16.25 | $254,120.89 | -8.3% | -12.6% | +95.9% | |
| Aug 21, 2024 | RDNT Radnet, Inc. | Murdock Michael N45 | EVP, Mergers And Acquisitions | Sell | 15,000 | $62.78 | $941,701.95 | -8.7% | +26.5% | +8.7% | |
| Aug 21, 2024 | GRAL Grail, Inc. | Ofman Joshua J. | President | Sell | 74,084 | $16.25 | $1,203,650.16 | -27.9% | -12.6% | +95.9% | |
| Aug 21, 2024 | MYGN Myriad Genetics Inc | Ancona Margaret | SVP, Chief Of Staff | Sell | 11,538 | $27.82 | $320,987.16 | -12.7% | -46.3% | -79.1% | |
| Aug 21, 2024 | CDNA Caredx, Inc. | Johnson Alexander L76 | See Remarks | Sell | 61,023 | $32.96 | $2,011,414.28 | -9.7% | -33.9% | -62.5% | |
| Aug 20, 2024 | CDNA Caredx, Inc. | Maag Peter84 | Director | Sell | 35,552 | $33.04 | $1,174,492.68 | -3.3% | -33.6% | -62.5% | |
| Aug 19, 2024 | CDNA Caredx, Inc. | Johnson Alexander L76 | See Remarks | Sell | 34,231 | $33.55 | $1,148,334.85 | -3.6% | -36.6% | -66.0% | |
| Aug 19, 2024 | WST West Pharmaceutical Services Inc | Witherspoon Charles63 | VP &Treasurer | Sell | 1,029 | $300.00 | $308,700.00 | -22.9% | +1.8% | -18.1% | |
| Aug 19, 2024 | MYGN Myriad Genetics Inc | Kumar Rashmi | Director | Sell | 7,500 | $28.01 | $210,075.00 | -8.8% | -46.1% | -80.5% | |
| Aug 19, 2024 | WGS Genedx Holdings Corp. | Opko Health, Inc. | 10% Owner | Sell | 139,824 | $34.02 | $4,756,875.36 | -1.7% | +100.1% | +239.6% | |
| Aug 15, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 5,583 | $118.91 | $663,895.23 | -1.4% | +31.7% | +33.3% | |
| Aug 15, 2024 | RVTY Revvity, Inc. | Michas Alexis P68 | Director | Sell | 850 | $118.62 | $100,827.00 | -9.9% | -0.2% | -24.3% | |
| Aug 15, 2024 | MTD Mettler Toledo International Inc/ | Magloth Christian66 | Head Of Human Resources | Sell | 1,000 | $1,422.97 | $1,422,970.00 | -57.7% | -12.3% | -8.5% | |
| Aug 15, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 12,000 | $121.01 | $1,452,124.80 | -4.0% | +31.7% | +33.3% | |
| Aug 15, 2024 | NEO Neogenomics Inc | Olivo Alicia C69 | General Counsel | Sell | 1,040 | $16.05 | $16,695.43 | -2.3% | +1.9% | -61.5% | |
| Aug 13, 2024 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 47,845 | $32.19 | $1,540,366.41 | -16.6% | +19.5% | -5.7% | |
| Aug 13, 2024 | WGS Genedx Holdings Corp. | Opko Health, Inc. | 10% Owner | Sell | 84,774 | $34.19 | $2,898,313.64 | -1.5% | +114.9% | +260.5% | |
| Aug 13, 2024 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 3,956 | $116.67 | $461,546.52 | -3.3% | +12.6% | +32.5% | |
| Aug 12, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 2,700 | $113.82 | $307,313.69 | -0.2% | +16.2% | +38.7% | |
| Aug 12, 2024 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,883 | $26.65 | $210,058.30 | -14.3% | +26.3% | -27.7% | |
| Aug 12, 2024 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 431 | $1.59 | $686.80 | -0.2% | -12.4% | -74.5% | |
| Aug 12, 2024 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 3,744 | $1.59 | $5,966.12 | -0.4% | -12.4% | -74.5% | |
| Aug 12, 2024 | BDSX Biodesix Inc | Vazquez Chris65 | Chief Accounting Officer | Sell | 209 | $1.59 | $333.04 | -0.9% | -12.4% | -74.5% | |
| Aug 12, 2024 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 975 | $1.59 | $1,553.67 | -0.3% | -12.4% | -74.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.